ACETO Corp (ACET) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
ACETO Reports Fiscal 2018 First Quarter Results
November 2, 2017 5:00 PM EDTPORT WASHINGTON, N.Y., Nov. 02, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), focused on the global marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the first quarter of fiscal 2018 ended September 30, 2017.
First Quarter Fiscal 2018 versus First Quarter Fiscal 2017
Net sales of $185.3 million versus $128.0 million, a 44.7% increaseGross profit of $40.0 million versus $30.8 million, a 29.7% increaseNet income of $0.5 million versus $4.4 million, a 89.6% decreaseDiluted EPS of $0.01 versus $0.15, an 93.3% decreaseNon-GAAP Adjusted Net Income of $10.7 million versus $8.3 million, a... More